Efficacy and Safety Study of Symbicort Turbuhaler in Chinese Patients With COPD

NCT00421122 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

315

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: budesonide/formoterol (Symbicort)
DRUG: budesonide (Pulmicort)
DRUG: terbutaline sulfate (Bricasol)

Sponsor

AstraZeneca